CD8⁺ T cell killing of MHC class I-deficient tumors

Nat Cancer. 2023 Sep;4(9):1214-1216. doi: 10.1038/s43018-023-00606-y.

Author

Christopher E Rudd^{1

2

3}

Affiliations

¹ Department of Medicine, Université de Montréal, Montreal, Quebec, Canada. christopher.e.rudd@umontreal.ca.
² Division of Endocrinology and Metabolism, Department of Medicine & Health Sciences, McGill University, Montreal, Quebec, Canada. christopher.e.rudd@umontreal.ca.
³ Division of Immunology Oncology, Centre de Recherche-Hôpital Maisonneuve-Rosemont (CR-HMR), Montreal, Quebec, Canada. christopher.e.rudd@umontreal.ca.

PMID: 37537302
DOI: 10.1038/s43018-023-00606-y

No abstract available

Publication types

Comment

MeSH terms

CD8-Positive T-Lymphocytes*
Cell Death
Genes, MHC Class I / genetics
Histocompatibility Antigens Class I / genetics
Humans
Neoplasms* / genetics

Substances

Histocompatibility Antigens Class I